📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-EarningsRead more

Brain+ ApS (BRAINP)

Currency in DKK
BRAINP Scorecard
Full Analysis
Significant return over the last week
Fair Value
Day's Range
52 wk Range
Prev. Close
Day's Range
52 wk Range
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
Fair Value Upside
BRAINP Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Stock generally trades with high price volatility

Brain+ ApS Company Profile

Brain+ A/S develops digital therapeutics for Alzheimer’s and dementia. It develops cognitive stimulation therapy (CST)-Assistant, a health tech solution to support scalable and delivery of group CST via a readily accessible preparation system, content adaptability and a standardized delivery form, which lessens the dependence of CST performance on therapists; CST - Home Care for use to extend and scale the delivery of CST to a home setting, enabling broader access to the therapy for a dementia population at limited costs; CST/ computerized cognitive training (CCT) combination product for individuals with mild cognitive impairment, combining cognitive stimulation therapy with computerized cognitive training to train cognitive function and potentially delay the transition to dementia; and Starry Night, a software based test designed to detect early signs of cognitive decline and enable early targeted intervention and treatment. Brain+ A/S was incorporated in 2012 and is based in Copenhagen, Denmark.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.